JMP securities has increased target from $7 to $10.Report not yet public.Interesting thing is that JMP is only assigning value to one of the programs. This leaves a lot of room to the upside as the clinical trials progress in the other two. Smufty
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar<